Table 2.

Genotype distribution in MI patients of different ages of onset, compared with age-matched healthy control subjects

MI (%)HC (%)ORP
FII 20210A carriers 16 of 500 (3.2) 5 of 500 (1) 3.3 .015  
 50 years or younger 2 of 46 (4.3) 3 of 373 (0.8) 5.6 .04  
 Older than 50 years 14 of 454 (3.1) 2 of 127 (1.6) 2.0 NS 
FVL carriers 23 of 500 (4.6) 23 of 500 (4.6) 1.0 NS 
 50 years or younger 6 of 46 (13.0) 18 of 373 (4.8) 3.0 .007  
 Older than 50 years 17 of 454 (3.8) 5 of 127 (3.9) 1.0 NS  
FXIII 34L carriers 235 of 500 (47.0) 239 of 500 (47.8) 1.0 NS 
 50 years or younger 19 of 46 (41.3) 176 of 373 (47.2) 0.8 NS  
 Older than 50 years 216 of 454 (47.6) 63 of 127 (49.6) 0.9 NS 
MI (%)HC (%)ORP
FII 20210A carriers 16 of 500 (3.2) 5 of 500 (1) 3.3 .015  
 50 years or younger 2 of 46 (4.3) 3 of 373 (0.8) 5.6 .04  
 Older than 50 years 14 of 454 (3.1) 2 of 127 (1.6) 2.0 NS 
FVL carriers 23 of 500 (4.6) 23 of 500 (4.6) 1.0 NS 
 50 years or younger 6 of 46 (13.0) 18 of 373 (4.8) 3.0 .007  
 Older than 50 years 17 of 454 (3.8) 5 of 127 (3.9) 1.0 NS  
FXIII 34L carriers 235 of 500 (47.0) 239 of 500 (47.8) 1.0 NS 
 50 years or younger 19 of 46 (41.3) 176 of 373 (47.2) 0.8 NS  
 Older than 50 years 216 of 454 (47.6) 63 of 127 (49.6) 0.9 NS 

or Create an Account

Close Modal
Close Modal